Falling Plasmodium knowlesi Malaria Death Rate among Adults despite Rising Incidence, Sabah, Malaysia, 2010-2014

Emerging Infectious Diseases

Volumn 22, Issue 1, 2016, Pages 41-48

  Rajahram, Giri S ^a   Barber, Bridget E ^b,c,d   William, Timothy ^a,b,e   Grigg, Matthew J ^b,c,d   Menon, Jayaram ^a   Yeo, Tsin W ^b,c,d,f   Anstey, Nicholas M ^b,c,d  

^a Queen Elizabeth Hospital   (Malaysia)

^b Infectious Diseases Society Sabah Menzies School of Health Research Clinical Research Unit   (Malaysia)

^c MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^d CHARLES DARWIN UNIVERSITY   (Australia)

^e Jesselton Medical Centre   (Malaysia)

^f NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; BILIRUBIN; CEFTRIAXONE; CHLOROQUINE; HEMOGLOBIN; PRIMAQUINE;

ABDOMINAL PAIN; ACUTE KIDNEY FAILURE; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ANTIMALARIAL ACTIVITY; ARTICLE; CASE REPORT; CLINICAL ARTICLE; CLINICAL FEATURE; DRY COUGH; FEMALE; FEVER; GLASGOW COMA SCALE; HEMODIALYSIS; HUMAN; MALE; METABOLIC ACIDOSIS; MICROSCOPY; MORTALITY RATE; MYALGIA; PARASITE COUNT; PLASMODIUM FALCIPARUM; PLASMODIUM KNOWLESI; PLASMODIUM KNOWLESI MALARIA; PLASMODIUM MALARIAE; POLYMERASE CHAIN REACTION; RIGOR; THORAX RADIOGRAPHY; THROMBOCYTOPENIA; INCIDENCE; MALARIA; MALAYSIA; MIDDLE AGED; MORTALITY; PATHOGENICITY;

ADULT; AGED; FEMALE; HUMANS; INCIDENCE; MALARIA; MALAYSIA; MALE; MIDDLE AGED; PLASMODIUM KNOWLESI;

EID: 85016520803     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/EID2201.151305     Document Type: Article

References (36)

1. William T, Jelip J, Menon J, Anderios F, Mohammad R, Awang Mohammad TA, et al. Changing epidemiology of malaria in Sabah, Malaysia: increasing incidence of Plasmodium knowlesi. Malar J. 2014;13:390. http://dx.doi.org/10.1186/1475-2875-13-390
2. William T, Rahman HA, Jelip J, Ibrahim MY, Menon J, Grigg MJ, et al. Increasing incidence of Plasmodium knowlesi malaria following control of P. falciparum and P. vivax malaria in Sabah, Malaysia. PLoS Negl Trop Dis. 2013;7:e2026. http://dx.doi.org/10.1371/journal.pntd.0002026
3. Sarawak State Health Department. Sarawak EPID News [cited 2015 Jun 6]. http://jknsarawak.moh.gov.my/en/modules/wfdownloads/viewcat.php?cid=31
4. Yusof R, Lau YL, Mahmud R, Fong MY, Jelip J, Ngian H, et al. High proportion of knowlesi malaria in recent malaria cases in Malaysia. Malar J. 2014;13:168. http://dx.doi.org/10.1186/1475-2875-13-168
5. Singh B, Daneshvar C. Human infections and detection of Plasmodium knowlesi. Clin Microbiol Rev. 2013;26:165-84. http://dx.doi.org/10.1128/CMR.00079-12
6. Barber BE, William T, Grigg MJ, Menon J, Auburn S, Marfurt J, et al. A prospective comparative study of knowlesi, falciparum and vivax malaria in Sabah, Malaysia: high proportion with severe disease from Plasmodium knowlesi and P. vivax but no mortality with early referral and artesunate therapy. Clin Infect Dis. 2013; 56:383-97. http://dx.doi.org/10.1093/cid/cis902
7. William T, Menon J, Rajahram G, Chan L, Ma G, Donaldson S, et al. Severe Plasmodium knowlesi malaria in a tertiary hospital, Sabah, Malaysia. Emerg Infect Dis. 2011;17:1248-55. http://dx.doi.org/10.3201/eid1707.101017
8. Barber BE, William T, Jikal M, Jilip J, Dhararaj P, Menon J, et al. Plasmodium knowlesi malaria in children. Emerg Infect Dis. 2011;17:814-20. http://dx.doi.org/10.3201/eid1705.101489
9. Barber BE, William T, Dhararaj P, Anderios F, Grigg MJ, Yeo TW, et al. Epidemiology of Plasmodium knowlesi malaria in northeast Sabah, Malaysia: family clusters and wide age distribution. Malar J. 2012;11:401. http://dx.doi.org/10.1186/1475-2875-11-401
10. Rajahram GS, Barber BE, William T, Menon J, Anstey NM, Yeo TW. Deaths due to Plasmodium knowlesi malaria in Sabah, Malaysia: association with reporting as P. malariae and delayed parenteral artesunate. Malar J. 2012;11:284. http://dx.doi.org/10.1186/1475-2875-11-284
11. Rajahram GS, Barber BE, Yeo TW, Tan WM, William T. Case report: fatal Plasmodium knowlesi malaria following an atypical clinical presentation and delayed diagnosis. Med J Malaysia. 2013;68:71-2.
12. Ministry of Health Malaysia. Management guidelines of malaria in Malaysia. 2014 [cited 2015 Aug 15]. http://www.moh.gov.my/english.php/pages/view/118
13. World Health Organization. Guidelines for the treatment of malaria. 3rd edition. Geneva: The Organization; 2015.
14. World Health Organization. Management of severe malaria: a practical handbook. 3rd edition. Geneva: The Organization; 2013.
15. World Health Organization. Severe malaria. Trop Med Int Health. 2014;19(Suppl 1):7-131. http://dx.doi.org/10.1111/tmi.12313_2
16. Department of Statistics Malaysia. Statistics. Sabah [cited 2015 Jun 6]. https://www.statistics.gov.my/index.php?r=column/cone&menu_id=dTZ0K2o4YXgrSDRtaEJyVmZ1R2h5dz09
17. Dondorp AM, Fanello CI, Hendriksen IC, Gomes E, Seni A, Chhaganlal KD, et al. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet. 2010;376:1647-57. http://dx.doi.org/10.1016/S0140-6736(10)61924-1
18. Daneshvar C, Davis TM, Cox-Singh J, Rafa'ee M, Zakaria S, Divis P, et al. Clinical and laboratory features of human Plasmodium knowlesi infection. Clin Infect Dis. 2009;49:852-60. http://dx.doi.org/10.1086/605439
19. Willmann M, Ahmed A, Siner A, Wong I, Woon L, Singh B, et al. Laboratory markers of disease severity in Plasmodium knowlesi infection: a case control study. Malar J. 2012;11:363. http://dx.doi.org/10.1186/1475-2875-11-363
20. Grigg MJ, William T, Menon J, Barber B, Wilkes CS, Price R, et al. Disease burden from P. vivax and P. knowlesi malaria in children in Sabah, Malaysia. In: Abstracts of the 5th International Conference of Research on Plasmodium vivax Malaria; Jimbaran, Bali, Indonesia; 2015 May 19-22. Jakarta: Eijkman-Oxford Clinical Research Unit; 2015.
21. Baird JK, Masbar S, Basri H, Tirtokusumo S, Subianto B, Hoffman SL. Age-dependent susceptibility to severe disease with primary exposure to Plasmodium falciparum. J Infect Dis. 1998; 178:592-5. http://dx.doi.org/10.1086/517482
22. Cox-Singh J, Davis TM, Lee KS, Shamsul SS, Matusop A, Ratnam S, et al. Plasmodium knowlesi malaria in humans is widely distributed and potentially life threatening. Clin Infect Dis. 2008;46:165-71. http://dx.doi.org/10.1086/524888
23. Ahmed MA, Cox-Singh J. Plasmodium knowlesi-an emerging pathogen. ISBT Science Series. 2015;10(Suppl 1):134-40. http://dx.doi.org/10.1111/voxs.12115
24. Lee CE, Adeeba K, Freigang G. Human Plasmodium knowlesi infections in Klang Valley, Peninsular Malaysia: a case series. Med J Malaysia. 2010;65:63-5.
25. Cox-Singh J, Hiu J, Lucas SB, Divis PC, Zulkarnaen M, Chandran P, et al. Severe malaria-a case of fatal Plasmodium knowlesi infection with post-mortem findings. Malar J. 2010;9:10. http://dx.doi.org/10.1186/1475-2875-9-10
26. Barber BE, William T, Grigg MJ, Yeo TW, Anstey NM. Limitations of microscopy to differentiate Plasmodium species in a region co-endemic for Plasmodium falciparum, Plasmodium vivax and Plasmodium knowlesi. Malar J. 2013;12:8. http://dx.doi.org/10.1186/1475-2875-12-8
27. Grigg MJ, William T, Dhanaraj P, Menon J, Barber BE, von Seidlein L, et al. A study protocol for a randomised open-label clinical trial of artesunate-mefloquine versus chloroquine in patients with non-severe Plasmodium knowlesi malaria in Sabah, Malaysia (ACT KNOW trial). BMJ Open. 2014;4:e006005. http://dx.doi.org/10.1136/bmjopen-2014-006005
28. Grigg MJ, William T, Dhanaraj P, Menon J, Barber B, von Seidlein L, et al. A randomized open-label clinical trial of artesunate-mefloquine versus chloroquine in patients with non-severe Plasmodium knowlesi malaria in Sabah, Malaysia (ACT KNOW trial). Lancet Infect Dis. 2015. In press.
29. Grigg MJ, William T, Menon J, Dhanaraj P, Barber B, Wilkes CS, et al. A randomized open-label clinical trial of artesunate-mefloquine versus chloroquine in patients with non-severe Plasmodium vivax malaria in Sabah, Malaysia. In: Abstracts of the 5th International Conference of Research on Plasmodium vivax Malaria; Jimbaran, Bali, Indonesia; 2015 May 19-22. Jakarta: Eijkman-Oxford Clinical Research Unit; 2015.
30. Valecha N, Pinto RGW, Turner GDH, Kumar A, Rodrigues S, Dubhashi NG, et al. Histopathology of fatal respiratory distress caused by Plasmodium vivax malaria. Am J Trop Med Hyg. 2009;81:758-62. http://dx.doi.org/10.4269/ajtmh.2009.09-0348
31. Lacerda MVG, Fragoso SCP, Alecrim MGC, Alexandre MAA, Magalhães BML, Siqueira AM, et al. Postmortem characterization of patients with clinical diagnosis of Plasmodium vivax malaria: to what extent does this parasite kill? Clin Infect Dis. 2012;55: e67-74. http://dx.doi.org/10.1093/cid/cis615
32. Anstey NM, Douglas NM, Poespoprodjo JR, Price R. Plasmodium vivax: clinical spectrum, risk factors and pathogenesis. Adv Parasitol. 2012;80:151-201. http://dx.doi.org/10.1016/B978-0-12-397900-1.00003-7
33. Douglas NM, Pontororing G, Lampah D, Yeo T, Kenangalem E, Poespoprodjo J, et al. Mortality attributable to Plasmodium vivax malaria: a clinical audit from Papua, Indonesia. BMC Med. 2014;12:217. http://dx.doi.org/10.1186/s12916-014-0217-z
34. McGready R, Wongsaen K, Chu C, Tun N, Chotivanich K, White N, et al. Uncomplicated Plasmodium vivax malaria in pregnancy associated with mortality from acute respiratory distress syndrome. Malar J. 2014;13:191. http://dx.doi.org/10.1186/1475-2875-13-191
35. Anstey NM, Russell B, Yeo TW, Price RN. The pathophysiology of vivax malaria. Trends Parasitol. 2009;25:220-7. http://dx.doi.org/10.1016/j.pt.2009.02.003
36. Siqueira AM, Lacerda MV, Magalhães BM, Mourão MP, Melo GC, Alexandre MA, et al. Characterization of Plasmodium vivax-associated admissions to reference hospitals in Brazil and India. BMC Med. 2015;13:57. http://dx.doi.org/10.1186/s12916-015-0302-y